Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
bs-0051R-PE-Cy3 Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, PE-Cy3 Conjugated Bioss 100ug 401 bs-0051R-PE-Cy3 Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, PE-Cy3 Conjugated Bioss 100ug 401
ASK
Publication
bs-0051R-PE Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, PE Conjugated Bioss 100ug 369 bs-0051R-PE Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, PE Conjugated Bioss 100ug 369
ASK
Publication
bs-0051R Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, Unconjugated Bioss 100ug 330 bs-0051R Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, Unconjugated Bioss 100ug 330 Publication
bs-0051R-PE-Cy7 Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, PE-Cy7 Conjugated Bioss 100ug 401 bs-0051R-PE-Cy7 Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, PE-Cy7 Conjugated Bioss 100ug 401
ASK
Publication
100-115 Human TRAIL TRAIL Shenandoah Biotechnology, Inc. 10ug 113.4 100-115 Human TRAIL TRAIL Shenandoah Biotechnology, Inc. 10ug 113.4 Publication
bs-0051R-Biotin Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, Biotin Conjugated Bioss 100ug 369 bs-0051R-Biotin Rabbit Anti-Melanoma Melan-A MART-1 Melanoma HumanB45 Polyclonal Antibody, Biotin Conjugated Bioss 100ug 369
ASK
Publication
bs-0051R-Cy5.5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-0051R-Cy5.5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268
ASK
Publication
bs-0051R-Cy5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-0051R-Cy5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268
ASK
Publication
bs-0051R-Cy3 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy3 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-0051R-Cy3 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy3 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268
ASK
Publication
bs-0051R-HRP Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, HRP conjugated Isotype: IgG Sepax 100ug Lyophilized 284 bs-0051R-HRP Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, HRP conjugated Isotype: IgG Sepax 100ug Lyophilized 284
ASK
Publication
bs-0051R-PE-Cy5.5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-0051R-PE-Cy5.5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300
ASK
Publication
bs-0051R-Cy7 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 268 bs-0051R-Cy7 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 268
ASK
Publication
bs-0051R-PE-Cy5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-0051R-PE-Cy5 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300
ASK
Publication
bs-0051R-FITC Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 bs-0051R-FITC Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304
ASK
Publication
bs-0051R-A555 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0051R-A555 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323
ASK
Publication
bs-0051R-A488 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0051R-A488 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323
ASK
Publication
bs-0051R-A350 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0051R-A350 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323
ASK
Publication
bs-0051R-A647 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0051R-A647 Rabbit Anti-Melanoma HMB45 Melanoma Melan-A MART-1 Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323
ASK
Publication
ME1004 Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003 US Biomax 314 ME1004 Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003 US Biomax 314
ASK
Publication
ME1001 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores US Biomax 266 ME1001 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores US Biomax 266
ASK
Publication
ME1003 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 US Biomax 266 ME1003 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 US Biomax 266
ASK
Publication
ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296 ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
M1586 pCAMBIA1105.1 (GusPlus™ lacZ, Hygromycin B Streptomycin Resistant Plant Expression Vector), Hygromycin B resistance gene for plant selection, streptomycin resistance, GusPlus™ reporter gene, lacZ for MarkerGene 186 M1586 pCAMBIA1105.1 (GusPlus™ lacZ, Hygromycin B Streptomycin Resistant Plant Expression Vector), Hygromycin B resistance gene for plant selection, streptomycin resistance, GusPlus™ reporter gene, lacZ for MarkerGene 186
ASK
Publication
Y104457 DcR1 TRAIL R3 ED2 ABM Goods 100 ug 1147 Y104457 DcR1 TRAIL R3 ED2 ABM Goods 100 ug 1147
ASK
Publication
000190A Trail R2 ABM Goods 250ul 621 000190A Trail R2 ABM Goods 250ul 621
ASK
Publication
3045-100 TRAIL Antibody Biovision 100 ug 282 3045-100 TRAIL Antibody Biovision 100 ug 282
ASK
Publication
000189A Trail ABM Goods 250ul 621 000189A Trail ABM Goods 250ul 621
ASK
Publication
Y104458 DcR2 TRAIL R4 ID ABM Goods 100 ug 1147 Y104458 DcR2 TRAIL R4 ID ABM Goods 100 ug 1147
ASK
Publication
5354-100 TRAIL Antibody Biovision 100 281 5354-100 TRAIL Antibody Biovision 100 281 Publication
Y050497 Anti ARS2(Arsenite resistance protein 2) ABM Goods 100ug 436.8 Y050497 Anti ARS2(Arsenite resistance protein 2) ABM Goods 100ug 436.8
ASK
Publication
Y104458 DcR2 TRAIL-R4 ID Antibody ABM Goods 100 ug 1015 Y104458 DcR2 TRAIL-R4 ID Antibody ABM Goods 100 ug 1015
ASK
Publication
Y104457 DcR1 TRAIL-R3 ED2 Antibody ABM Goods 100 ug 1015 Y104457 DcR1 TRAIL-R3 ED2 Antibody ABM Goods 100 ug 1015
ASK
Publication
Y050497 Anti-ARS2(Arsenite-resistance protein 2) Antibody ABM Goods 100ug 386.4 Y050497 Anti-ARS2(Arsenite-resistance protein 2) Antibody ABM Goods 100ug 386.4
ASK
Publication
228-11549-1 Recombinant Human TRAIL Proteins Ray Biotech 10 147 228-11549-1 Recombinant Human TRAIL Proteins Ray Biotech 10 147
ASK
Publication
rAP-0167-50 TRAIL (Human) recombinant proteins AngoiPro 50.00 ug 279 rAP-0167-50 TRAIL (Human) recombinant proteins AngoiPro 50.00 ug 279 Publication
228-11550-3 Recombinant Human TRAIL (aa 114-281) Proteins Ray Biotech 1mg 1658 228-11550-3 Recombinant Human TRAIL (aa 114-281) Proteins Ray Biotech 1mg 1658
ASK
Publication
4354-50 TRAIL Apo2L, human recombinant Biovision 50 μg 247 4354-50 TRAIL Apo2L, human recombinant Biovision 50 μg 247
ASK
Publication
rAP-0167-10 TRAIL (Human) recombinant proteins AngoiPro 10.00 ug 133 rAP-0167-10 TRAIL (Human) recombinant proteins AngoiPro 10.00 ug 133 Publication
ELH-TRAILR2-001 Human TRAIL R2 Ray Biotech One 96-Well Strip Microplate Kit 362 ELH-TRAILR2-001 Human TRAIL R2 Ray Biotech One 96-Well Strip Microplate Kit 362 Publication
228-11550-2 Recombinant Human TRAIL (aa 114-281) Proteins Ray Biotech 50 240 228-11550-2 Recombinant Human TRAIL (aa 114-281) Proteins Ray Biotech 50 240
ASK
Publication
4354-1000 TRAIL Apo2L, human recombinant Biovision 1 mg 1577 4354-1000 TRAIL Apo2L, human recombinant Biovision 1 mg 1577
ASK
Publication
228-11550-1 Recombinant Human TRAIL (aa 114-281) Proteins Ray Biotech 10 205 228-11550-1 Recombinant Human TRAIL (aa 114-281) Proteins Ray Biotech 10 205
ASK
Publication
RBMS2004R ELISA Human , TRAIL Biovendor 96 wells (1 kit) 528 RBMS2004R ELISA Human , TRAIL Biovendor 96 wells (1 kit) 528 Publication
4354-10 TRAIL Apo2L, human recombinant Biovision 10 μg 134 4354-10 TRAIL Apo2L, human recombinant Biovision 10 μg 134 Publication
228-11549-3 Recombinant Human TRAIL Proteins Ray Biotech 1mg 1370 228-11549-3 Recombinant Human TRAIL Proteins Ray Biotech 1mg 1370
ASK
Publication
Y104456 DcR1 TRAIL R3, Extracellular Domain ABM Goods 100 ug 1147 Y104456 DcR1 TRAIL R3, Extracellular Domain ABM Goods 100 ug 1147
ASK
Publication
228-11549-2 Recombinant Human TRAIL Proteins Ray Biotech 50 205 228-11549-2 Recombinant Human TRAIL Proteins Ray Biotech 50 205
ASK
Publication
Y062543 Anti Breast Cancer Resistance Protein produced in rabbit ABM Goods 100ul 1120 Y062543 Anti Breast Cancer Resistance Protein produced in rabbit ABM Goods 100ul 1120
ASK
Publication
ELH-TRAILR1-001 Custom Human TRAIL R1 Ray Biotech One 96-Well Strip Microplate Kit 542 ELH-TRAILR1-001 Custom Human TRAIL R1 Ray Biotech One 96-Well Strip Microplate Kit 542 Publication
rAP-0168-2 TRAIL 114-281aa (Human) recombinant proteins AngoiPro 2.00 ug 133 rAP-0168-2 TRAIL 114-281aa (Human) recombinant proteins AngoiPro 2.00 ug 133 Publication
rAP-0168-10 TRAIL 114-281aa (Human) recombinant proteins AngoiPro 10.00 ug 279 rAP-0168-10 TRAIL 114-281aa (Human) recombinant proteins AngoiPro 10.00 ug 279 Publication
Y104456 DcR1 TRAIL-R3, Extracellular Domain Antibody ABM Goods 100 ug 1015 Y104456 DcR1 TRAIL-R3, Extracellular Domain Antibody ABM Goods 100 ug 1015
ASK
Publication
MD-14-0257P Recombinant Human TRAIL Apo2L Proteins Ray Biotech 50 309 MD-14-0257P Recombinant Human TRAIL Apo2L Proteins Ray Biotech 50 309 Publication
Y062543 Anti-Breast Cancer Resistance Protein produced in rabbit Antibody ABM Goods 100ul 994 Y062543 Anti-Breast Cancer Resistance Protein produced in rabbit Antibody ABM Goods 100ul 994
ASK
Publication
Y062542 Monoclonal Anti Breast Cancer Resistance Protein produced in mouse ABM Goods 100ul 965 Y062542 Monoclonal Anti Breast Cancer Resistance Protein produced in mouse ABM Goods 100ul 965
ASK
Publication
Y062541 Monoclonal Anti Breast Cancer Resistance Protein produced in mouse ABM Goods 100ul 965 Y062541 Monoclonal Anti Breast Cancer Resistance Protein produced in mouse ABM Goods 100ul 965
ASK
Publication
RGP023R ELISA Human , Trail Receptor 2 (CD262) Biovendor 96 wells (1 kit) 528 RGP023R ELISA Human , Trail Receptor 2 (CD262) Biovendor 96 wells (1 kit) 528 Publication
RGP022R ELISA Human , Trail Receptor 1 (CD261) Biovendor 96 wells (1 kit) 528 RGP022R ELISA Human , Trail Receptor 1 (CD261) Biovendor 96 wells (1 kit) 528
ASK
Publication
RGP024R ELISA Human , Trail Receptor 3 (CD263) Biovendor 96 wells (1 kit) 528 RGP024R ELISA Human , Trail Receptor 3 (CD263) Biovendor 96 wells (1 kit) 528 Publication
Y062541 Monoclonal Anti-Breast Cancer Resistance Protein produced in mouse Antibody ABM Goods 100ul 857 Y062541 Monoclonal Anti-Breast Cancer Resistance Protein produced in mouse Antibody ABM Goods 100ul 857
ASK
Publication
Y062542 Monoclonal Anti-Breast Cancer Resistance Protein produced in mouse Antibody ABM Goods 100ul 857 Y062542 Monoclonal Anti-Breast Cancer Resistance Protein produced in mouse Antibody ABM Goods 100ul 857
ASK
Publication
A00019.0025 Melanoma; Clone HMB45 Scy tek 25 ml Ready-to-use 646 A00019.0025 Melanoma; Clone HMB45 Scy tek 25 ml Ready-to-use 646
ASK
Publication
A00019 Melanoma; Clone HMB45 Scy tek 6 ml Ready-to-use 221 A00019 Melanoma; Clone HMB45 Scy tek 6 ml Ready-to-use 221
ASK
Publication
A20019 Melanoma; Clone HMB45 Scy tek 2 ml Ready-to-use 137 A20019 Melanoma; Clone HMB45 Scy tek 2 ml Ready-to-use 137
ASK
Publication
R1235218A-10 Total RNA - Human Tumor Tissue Melanoma Biochain 10 290 R1235218A-10 Total RNA - Human Tumor Tissue Melanoma Biochain 10 290 Publication
IMLNM-SER Cancer samples: Melanoma Patient Serum Innovative Research INC Each 302 IMLNM-SER Cancer samples: Melanoma Patient Serum Innovative Research INC Each 302
ASK
Publication
IMLNM-N Cancer Samples: Melanoma Patient Plasma Innovative Research INC Each 302 IMLNM-N Cancer Samples: Melanoma Patient Plasma Innovative Research INC Each 302
ASK
Publication
P1235218A Total Protein Human Tumor Tissue Melanoma Biochain 1 mg 386 P1235218A Total Protein Human Tumor Tissue Melanoma Biochain 1 mg 386 Publication
21408 Melanoma associated antigen D1 Antibody Host Species Rabbit polyclonal SignalWay Antibody S.A.B 50 ug 143 21408 Melanoma associated antigen D1 Antibody Host Species Rabbit polyclonal SignalWay Antibody S.A.B 50 ug 143
ASK
Publication
ME1002 Malignant melanoma and normal tissue array, 50 cases 100 cores US Biomax 266 ME1002 Malignant melanoma and normal tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
ME2081 Mid density malignant melanoma and normal tissue array, 104 cases 208 cores US Biomax 456 ME2081 Mid density malignant melanoma and normal tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
ME801 Malignant melanoma tissue array, 80 cases 80 cores, replaced by ME804 US Biomax 231 ME801 Malignant melanoma tissue array, 80 cases 80 cores, replaced by ME804 US Biomax 231
ASK
Publication
ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231 ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases 48 cores US Biomax 231
ASK
Publication
ME241 Multiple melanoma tissue array with normal tissues, 12 cases 24 cores US Biomax 88 ME241 Multiple melanoma tissue array with normal tissues, 12 cases 24 cores US Biomax 88
ASK
Publication
ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456 ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores US Biomax 456
ASK
Publication
ME481 Multiple melanoma tissue array with normal skin tissues, 48 cases 48 cores US Biomax 160 ME481 Multiple melanoma tissue array with normal skin tissues, 48 cases 48 cores US Biomax 160
ASK
Publication
ME242 Low density malignant melanoma array, with stage and grade info, 24 cases 24 cores US Biomax 88 ME242 Low density malignant melanoma array, with stage and grade info, 24 cases 24 cores US Biomax 88
ASK
Publication
ME802 Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011 US Biomax 266 ME802 Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011 US Biomax 266
ASK
Publication
ME482 Malignant melanoma array with matched normal tissue control, stage and TNM, 48 cases 48 cores US Biomax 189 ME482 Malignant melanoma array with matched normal tissue control, stage and TNM, 48 cases 48 cores US Biomax 189
ASK
Publication
ELM-TRAIL-001 Custom Mouse TRAIL ELISA ELISA Ray Biotech One 96-Well Strip Microplate Kit 542 ELM-TRAIL-001 Custom Mouse TRAIL ELISA ELISA Ray Biotech One 96-Well Strip Microplate Kit 542 Publication
24009 Primary antibody Trail Antibody, Source Rabbit SignalWay Antibody S.A.B 100ug 364 24009 Primary antibody Trail Antibody, Source Rabbit SignalWay Antibody S.A.B 100ug 364
ASK
Publication
ME207 High density (69 cases 207 cores), multiple primary melanoma, metastatic and normal tissues array US Biomax 456 ME207 High density (69 cases 207 cores), multiple primary melanoma, metastatic and normal tissues array US Biomax 456
ASK
Publication
ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266 ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266
ASK
Publication
ELH-TRAILR4-001 Human TRAIL R4 ELISA ELISA Ray Biotech One 96-Well Strip Microplate Kit 362 ELH-TRAILR4-001 Human TRAIL R4 ELISA ELISA Ray Biotech One 96-Well Strip Microplate Kit 362 Publication
M1580 MarkerGene™ Multiple Drug Resistance Microtiterplate Assay Kit, High-throughput assay system based on measurement of efflux of green fluorescent dye known to bind to MDR transporters ABCG2 and ABCB1 MarkerGene 310 M1580 MarkerGene™ Multiple Drug Resistance Microtiterplate Assay Kit, High-throughput assay system based on measurement of efflux of green fluorescent dye known to bind to MDR transporters ABCG2 and ABCB1 MarkerGene 310
ASK
Publication
ME803 Malignant melanoma array with matched and unmatched normal skin tissue control, with stage and TNM, 80 cases 80 cores US Biomax 266 ME803 Malignant melanoma array with matched and unmatched normal skin tissue control, with stage and TNM, 80 cases 80 cores US Biomax 266
ASK
Publication
ME207b High density (69 cases 207 cores), multiple primary melanoma, metastatic and normal skin tissue array block US Biomax 40981 ME207b High density (69 cases 207 cores), multiple primary melanoma, metastatic and normal skin tissue array block US Biomax 40981
ASK
Publication
M1587 pCAMBIA1105.1R Vecotr (GusPlus™ Hygromycin B Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B resistance gene, stre MarkerGene 186 M1587 pCAMBIA1105.1R Vecotr (GusPlus™ Hygromycin B Streptomycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, Hygromycin B resistance gene, stre MarkerGene 186
ASK
Publication
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90 T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
T383 Malignant melanoma test tissue array, with normal skin tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 T383 Malignant melanoma test tissue array, with normal skin tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T382 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88 T382 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88
ASK
Publication
T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
M1596 pCAMBIA1305.1 Vector (GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186 M1596 pCAMBIA1305.1 Vector (GusPlus™ Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
T386 Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 US Biomax 88 T386 Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 US Biomax 88
ASK
Publication
M1592 pCAMBIA1301 Vector (gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance genes, MarkerGene 186 M1592 pCAMBIA1301 Vector (gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance genes, MarkerGene 186
ASK
Publication
M1595 pCAMBIA1304 Vector (gusA mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186 M1595 pCAMBIA1304 Vector (gusA mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1594 pCAMBIA1303 Vector (mgfp5 gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186 M1594 pCAMBIA1303 Vector (mgfp5 gusA Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, MarkerGene 186
ASK
Publication
M1593 pCAMBIA1302 Vector (mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, mgfp MarkerGene 186 M1593 pCAMBIA1302 Vector (mgfp5 Hygromycin B Kanamycin Resistant Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC18 poly-linker, kanamycin and hygromycin B resistance, mgfp MarkerGene 186
ASK
Publication
T385 Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386 US Biomax 88 T385 Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386 US Biomax 88
ASK
Publication
T381 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385 US Biomax 88 T381 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385 US Biomax 88
ASK
Publication
BC21011 Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 US Biomax 231 BC21011 Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 US Biomax 231
ASK
Publication
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
M1704 pCAMBIA1391 Vector (gusA Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC9 poly-linker, kanamycin and hygromycin B resistance, g MarkerGene 186 M1704 pCAMBIA1391 Vector (gusA Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), Restriction sites for modular plasmid modifications, pUC9 poly-linker, kanamycin and hygromycin B resistance, g MarkerGene 186
ASK
Publication
M1705 pCAMBIA1391Xa Vector (Fusible gusA (ORFa)Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fusi MarkerGene 186 M1705 pCAMBIA1391Xa Vector (Fusible gusA (ORFa)Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fusi MarkerGene 186
ASK
Publication
M1582 pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal pepti MarkerGene 186 M1582 pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal pepti MarkerGene 186
ASK
Publication
M1700 pCAMBIA1381Xb Vector (Fusible gusA(ORF b)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186 M1700 pCAMBIA1381Xb Vector (Fusible gusA(ORF b)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186
ASK
Publication
M1599 pCAMBIA1381Xa Vector (Fusible gusA(ORF a)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186 M1599 pCAMBIA1381Xa Vector (Fusible gusA(ORF a)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon for fusion of MarkerGene 186
ASK
Publication
M1701 pCAMBIA1381Xc Vector (Fusible gusA(ORF c)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA no start codon to allow fusion of MarkerGene 186 M1701 pCAMBIA1381Xc Vector (Fusible gusA(ORF c)Hygromycin B Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA no start codon to allow fusion of MarkerGene 186
ASK
Publication
M1707 pCAMBIA1391Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA, lacZ gene for white blue selection, 20UG MarkerGene 186 M1707 pCAMBIA1391Z Vector (gusA lacZ Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC8 poly-linker, kanamycin and hygromycin B resistance, gusA, lacZ gene for white blue selection, 20UG MarkerGene 186
ASK
Publication
M1706 pCAMBIA1391Xc Vector (Fusible gusA (ORF c) Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fu MarkerGene 186 M1706 pCAMBIA1391Xc Vector (Fusible gusA (ORF c) Hygromycin B Kanamycin Resistant pUC9 Plant Expression Vector), pUC9 poly-linker, kanamycin and hygromycin B resistance, gusA with no start codon to allow fu MarkerGene 186
ASK
Publication
M1581 pCAMBIA0305.1 Vector, (GusPlus™ No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance gene, GusPlus™ reporter gene, 20UG MarkerGene 186 M1581 pCAMBIA0305.1 Vector, (GusPlus™ No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance gene, GusPlus™ reporter gene, 20UG MarkerGene 186
ASK
Publication
M1583 pCAMBIA0380 Vector (No Reporter, No Bacterial Selection Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, no plant selection gene, kanamycin resistance gene, no reporter gene, 20UG MarkerGene 186 M1583 pCAMBIA0380 Vector (No Reporter, No Bacterial Selection Kanamycin Resistant pUC8 Plant Expression Vector), pUC8 poly-linker, no plant selection gene, kanamycin resistance gene, no reporter gene, 20UG MarkerGene 186
ASK
Publication
  Cat_Number Product name Supplier Quantity Price Tech More